Latest Commercialization News

NeuroScientific Biopharmaceuticals reveals compelling clinical evidence supporting its StemSmart MSC therapy for severe steroid-refractory graft versus host disease, advancing its strategic acquisition plans.

Singular Health Group has inked a $1.3 million contract with Provider Network Solutions to deploy its 3DICOM imaging platform across key US states, backed by an $8 million capital raise to fuel national expansion.

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

Eclipse Metals confirms a significant inferred resource of rare earth elements at its Grønnedal Project in Greenland, highlighting coarse-grained mineralogy and efficient processing potential that could position it as a key Western supplier.

Aurelia Metals has released its FY26 production, cost, and capital guidance alongside an aspirational outlook for FY27 and FY28, highlighting key operational shifts and investment in the Cobar region.

Euro Manganese has signed a non-binding term sheet with UK-based Integrals Power to supply high-purity manganese sulphate for next-generation LMFP battery cathodes, aiming to strengthen sustainable battery supply chains.

Everest Metals has been accepted into the US Defence Industrial Base Consortium, unlocking strategic collaboration and funding opportunities for its Mt Edon Rubidium Project in Western Australia. This milestone advances Australia’s first commercial rubidium production, addressing critical global supply shortages.

Keybridge Capital has lodged formal applications with the Takeovers Panel contesting Yowie Group’s off-market takeover offer, citing alleged legal circumvention and disclosure issues. The dispute raises questions about control dynamics and shareholder rights in the unfolding corporate tussle.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Opyl Limited’s AI platform TrialKey has partnered with UK insurer Innovatrix to launch a pioneering parametric insurance product that protects biotech firms from the financial risks of clinical trial failures.

Lithium Universe Limited has acquired exclusive global rights to a pioneering microwave-based technology for recycling photovoltaic solar panels, offering a strategic pivot while awaiting lithium market recovery.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.